1. Infection in neutropenic patients with cancer.
- Author
-
Bow EJ
- Subjects
- APACHE, Anti-Bacterial Agents therapeutic use, Antifungal Agents therapeutic use, Antineoplastic Agents therapeutic use, Chemoprevention, Comorbidity, Cytotoxins therapeutic use, Fever, Hospital Mortality, Humans, Intensive Care Units statistics & numerical data, Multiple Organ Failure etiology, Multiple Organ Failure mortality, Neoplasms drug therapy, Neoplasms mortality, Neutropenia chemically induced, Neutropenia microbiology, Neutropenia mortality, Sepsis drug therapy, Sepsis mortality, Syndrome, Antineoplastic Agents adverse effects, Cytotoxins adverse effects, Neoplasms complications, Neutropenia complications, Sepsis etiology
- Abstract
Neutropenic fever sepsis syndromes are common among patients with cancer who are receiving intensive cytotoxic systemic therapy. Recognition of the syndromes and timely initial antibacterial therapy is critical for survival and treatment success. Outcomes are linked to myeloid reconstitution and recovery from neutropenia, control of active comorbidities, and appropriate treatment of the infections that underlie the sepsis syndrome. Hematologists and oncologists must be clear about the prognosis and treatment goals to work effectively with critical care physicians toward the best outcomes for patients with cancer who develop neutropenic sepsis syndromes., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF